Actelion Receives FDA Approval of Tracleer (bosentan) for Use in Pediatric Patients with Pulmonary Arterial Hypertension

OLYMPUS DIGITAL CAMERA

SOUTH SAN FRANCISCO, Calif, September 6, 2017 – Actelion Pharmaceuticals US, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, announced today that the U.S. Food and Drug Administration (FDA) has approved a new 32 mg tablet for oral …

Read more

AbbVie Receives CHMP Positive Opinion for HUMIRA® (adalimumab) for the Treatment of Pediatric Patients with Chronic Non-infectious Anterior Uveitis

20130316_145725

[1] “Childhood uveitis is a challenging condition often associated with delays in diagnosis and high morbidity,” said Professor Athimalaipet Ramanan, pediatric rheumatologist at University Hospitals Bristol NHS Trust and principal investigator of the …

Read more

AbbVie Receives CHMP Positive Opinion for HUMIRA (adalimumab) for the Treatment of Pediatric Patients with Chronic Non-infectious Anterior Uveitis

_MG_9368

[1] “Childhood uveitis is a challenging condition often associated with delays in diagnosis and high morbidity,” said Professor Athimalaipet Ramanan, pediatric rheumatologist at University Hospitals Bristol NHS Trust and principal investigator of the …

Read more